Based on pooled results of early COVID-19 data, chronic liver disease seems to play a minor role in influencing patient progression towards the severe form of disease. A non-significant trend towards increased odds of mortality in COVID-19 patients with chronic liver disease should continue to be evaluated in larger studies. Therefore, data to-date would not apparently support the inclusion of chronic liver disease into risk stratification models as clinical predictor of severe disease.
Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis
Lippi, Giuseppe;
2021-01-01
Abstract
Based on pooled results of early COVID-19 data, chronic liver disease seems to play a minor role in influencing patient progression towards the severe form of disease. A non-significant trend towards increased odds of mortality in COVID-19 patients with chronic liver disease should continue to be evaluated in larger studies. Therefore, data to-date would not apparently support the inclusion of chronic liver disease into risk stratification models as clinical predictor of severe disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
